Paper Details

  1. Home
  2. Paper Details

Immunogenicity of Haemophilus influenzae b conjugate vaccine (HibTITER) and safety of HibTITER and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER in infants two months of age: a preliminary report.

Author: ChangP F, ChiuH H, HuangL M, LeeC Y, LeeP I, TasiS Y

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

HibTITER, a conjugate Haemophilus influenzae type b vaccine, is safe and highly immunogenic when administered concurrently with DTP vaccine.
Paper Details　
Original Abstract of the Article :
A study was undertaken to evaluate the safety and immunongenicity of a conjugate Haemophilus influenzae type b (Hib) vaccine (HibTITER) when administered concurrently with DTP (diphteria, tetanus and pertussis) vaccine in separate syringes. A total of 90 healthy children (45 per group) were randomiz...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10592815

データ提供：米国国立医学図書館（NLM）

HibTITER Vaccine: A Safe and Effective Journey Across the Desert of Childhood Infections

The desert of childhood infections can be a dangerous place, filled with threats like Haemophilus influenzae type b (Hib). HibTITER, a conjugate Hib vaccine, promises to protect children from this dangerous pathogen. This study, a quest for a safe and effective vaccine, evaluated the immunogenicity and safety of HibTITER when administered concurrently with DTP (diphtheria, tetanus, and pertussis) vaccine.

Navigating the Desert with HibTITER: A Safe and Effective Journey

The study, conducted on 90 healthy infants, found that HibTITER was highly immunogenic and safe when administered concurrently with DTP vaccine. The results, like a well-stocked caravan, demonstrate the effectiveness of HibTITER in protecting children from Hib infection. The study also suggests that combining HibTITER with DTP vaccine into a single vaccine, like combining multiple supplies into one compact package, could simplify the vaccination process for parents and healthcare providers.

Protecting Our Children: A Journey of Vaccination

The study reinforces the importance of vaccination in protecting children from serious infections. HibTITER, like a sturdy camel carrying a precious cargo, offers a safe and effective way to protect children from the threat of Hib infection. By ensuring that children receive the recommended vaccines, we can protect them from the dangers of the desert of childhood infections and help them thrive in a healthy environment.

Dr. Camel's Conclusion

This research provides strong evidence for the safety and efficacy of HibTITER vaccine. The study demonstrates that HibTITER can be safely and effectively administered concurrently with DTP vaccine, offering a convenient and protective solution for parents and healthcare providers. By embracing vaccination, we can ensure that our children have a safe and healthy journey through the desert of childhood infections.
Date :
  1. Date Completed 1999-12-22
  2. Date Revised 2005-03-04
Further Info :

Pubmed ID

10592815

DOI: Digital Object Identifier

10592815

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.